Gloria Interchem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 72.83%
- Profit Growth 231.15%
- Ebitda 393.17%
- Net Worth 22.80%
- Total Assets 66.43%
About Gloria Interchem
Gloria Interchem Private Limited (GIPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 February 2016 (Eight years and 11 months 9 days old ). Its registered office is in Vadodara, Gujarat.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akhil Shah and Manoj Shah serve as directors at the Company.
Company Details
-
LocationVadodara, Gujarat
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232GJ2016PTC086184
-
Company No.
086184
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Feb 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Gloria Interchem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akhil Shah
|
Director | 22-Feb-2016 | Current |
|
Manoj Shah
|
Director | 22-Feb-2016 | Current |
Financial Performance of Gloria Interchem.
Gloria Interchem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.83% increase. The company also saw a substantial improvement in profitability, with a 231.15% increase in profit. The company's net worth Soared by an impressive increase of 22.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gloria Interchem?
Unlock access to Gloria Interchem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Zeron Pharma Private LimitedManoj Shah is a mutual person
-
Lexine Technochem Private LimitedAkhil Shah and Manoj Shah are mutual person
-
Akhil Healthcare Private LimitedManoj Shah is a mutual person
-
Vr Castor Derivatives Private LimitedAkhil Shah and Manoj Shah are mutual person
-
Medilink Finechem Private Limited
Manoj Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gloria Interchem?
Unlock and access historical data on people associated with Gloria Interchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gloria Interchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gloria Interchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
